Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations

Similar documents
Quantitation by High Resolution Mass Spectrometry: Case Study of TOF MS for the Quantitation of Allopurinol from Human Plasma

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Discovery Metabolomics - Quantitative Profiling of the Metabolome using TripleTOF Technology

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Modernizing the Forensic Lab with LC-MS/MS Technology

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Improving Selectivity in Quantitative Analysis Using MS 3 on a Hybrid Quadrupole-Linear Ion Trap Mass Spectrometer

Ultra-Fast Forensic Toxicological Screening and Quantitation under 3 Minutes using SCIEX X500R QTOF System and SCIEX OS 1.

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Comprehensive Forensic Toxicology Screening in Serum using On-Line SPE LC-MS/MS

LC-MS/MS Solutions for Comprehensive Cannabis Analysis

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Advanced Tools to Screen for Targeted and Nontargeted Contaminants in Food Samples. André Schreiber AB SCIEX, Concord, Ontario (Canada)

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

Identification of Ginsenosides Using the SCIEX X500R QTOF System

Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System

Made For Routine Food, Environment, and Forensic Testing

Key Advantages of Comprehensive Cannabis Analysis

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

A Novel Platform of On-line Sample Pre-treatment and LC/MS/MS Analysis for Screening and Quantitation of Illicit Drugs in Urine

Increased Identification Coverage and Throughput for Complex Lipidomes

Alcohol Biomarkers by UHPLC-MS/MS

Ultra High Definition Optimizing all Analytical Dimensions

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Amadeo R. Fernández-Alba

4-Fluoroethamphetamine

Validation of an Automated Method to Remove

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Towards High Resolution MS in Regulated Bioanalysis

Latest Innovations in LC/MS/MS from Waters for Metabolism and Bioanalytical Applications

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

UPLC-HRMS: A tool for multi-residue veterinary drug methods

Moving from targeted towards non-targeted approaches

Quadrupole and Ion Trap Mass Analysers and an introduction to Resolution

Workflow for Screening and Quantification of the SAMHSA (NIDA) Panel in Urine Using UHPLC-TOF

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

A NOVEL METHOD OF M/Z DRIFT CORRECTION FOR OA-TOF MASS SPECTROMETERS BASED ON CONSTRUCTION OF LIBRARIES OF MATRIX COMPONENTS.

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Application Note # LCMS-89 High quantification efficiency in plasma targeted proteomics with a full-capability discovery Q-TOF platform

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Drugs of Abuse in Oral Fluids: Automated SPE Extraction and LC/MS/MS Determination using a Robotic Autosampler

High resolution mass spectrometry for bioanalysis at Janssen. Current experiences and future perspectives

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Opiates, Opioids and Benzodiazepines, Amphetamines & Illicit Drug Forensic Analysis by LC/MS

PAIN PANEL. Research and Solutions

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Toxicology Screening of Whole Blood Extracts Using GC/Triple Quadrupole/MS

Mass Spectrometry Made Simple for Clinical Diagnostic Labs

Sue D Antonio Application Chemist Cedar Creek, TX

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Chemical Analysis Business Operations Waters Corporation Milford MA

Analysis of drugs of abuse in biological matrix using Time of Flight technology

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

APPLICATIONS OF SMALL MOLECULE LCMS FOR FORENSICS AND TOXICOLOGY. Elliott Jones, Small Molecule LCMS Group Leader AB/SCIEX, Foster City CA

PosterREPRINT RAPID, SELECTIVE SCREENING OF URINE SAMPLES FOR GLUCURONIDES BY LC/MS/MS INTRODUCTION ABSTRACT

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

How to Use TOF and Q-TOF Mass Spectrometers

Quantitative Analysis of -Hydroxybutyrate in Hair Using Target Analyte Finding Processing of Comprehensive GC-HRT Data

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Determination of Selected Illegal Drugs and its Important Metabolites in Waste Water by Large Volume Direct Injection HPLC-MS/MS

Screening and Speciation of Raw and Processed Meat Products

Agilent s LC/MS Portfolio and Applications Examples

SelexION Technology for Lipid Analysis: Pushing the Boundaries of Lipidomics

SCIEX Vitamin D 200M Assay for the Topaz System

METHAMPHETAMINE & AMPHETAMINE

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

NEW. Kinetex. Biphenyl TMS TMS TMS TMS. Selectivity that a C18 just can t give you!

Determination of Amantadine Residues in Chicken by LCMS-8040

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

PosterReprint OVERVIEW

LC/MS/MS Analysis of Gabapentin, and Opiates. Applications. Presentation Outline. Polarity, MW and Volatility LC/MS Triple Quad Components

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

PAIN PANEL. Application Guide. Screen 41 compounds in under 4 minutes

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

The New 6495 Triple Quadrupole LC/MS

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Characterization of an Unknown Compound Using the LTQ Orbitrap

INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

Development of a Screening Analysis by LC Time-Of-Flight MS for Drugs of Abuse Application

Agilent Clinical LC/MS: Review of Established LC-MS QQQ Clinical Research Applications. dr. Jan Srbek, HPST. Page 1

A FORENSIC TOXICOLOGY METHOD FOR THE DETERMINATION OF DESOMORPHINE, HEROIN, METHADONE, BUPRENORPHINE AND METABOLITES IN URINE USING LC/MS QQQ

Achieve Broad Lipid Quantitation using a High-Throughput Targeted Lipidomics Method

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Transcription:

Advancing your Forensic Toxicology Analyses; Adopting the Latest in Mass Spectrometry Innovations For Research Use Only. Not for use in diagnostic procedures. 1 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Goal of analytical chemistry = Separate / differentiate analytes from other components Analyte Other components Most of the sample Masks the analyte Highly selective tools are required to filter out the other components 2 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Mass Spectrometry By measuring the mass of the analytes, mass spectrometers provide enhanced selectivity over other types of detectors. Detector A mass spectrometer is essentially a molecular scale Quadrupole MS systems are mass filters. Only the ion of interest is allowed to reach the detector 3 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Single Quadrupole (MS) Lower selectivity Many interferences Triple Quadrupole (MS/MS) Excellent selectivity Few interferences XIC of +Q1 MI (68 ions): 253.2 amu from Sample 13 (1ng/ml Q in soil) of comparison... Max. 6.7e4 cps. XIC of +MRM (34 pairs): 253.2/171.2 amu from Sample 14 (1ng/ml QqQ in soil) of c... Max. 6620.0 cps. 1.6e5 1.5e5 1.4e5 1.3e5 6500 6000 5500 6.9 1.2e5 5000 1.1e5 4500 In te n s ity, c p s 1.0e5 9.0e4 8.0e4 7.0e4 6.0e4 5.0e4 4.0e4 3.0e4 2.0e4 1.0e4 0.6 7.1 9.6 11.1 In te n s ity, c p s 4000 3500 3000 2500 2000 1500 1000 500 0.0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time, min 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time, min MS/MS provides far superior selectivity, therefore fewer interferences, because fragmentation patterns are so specific to each parent ion. 4 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Key Features of AB SCIEX LC-MS/MS Systems AB SCIEX Triple Quad System QTRAP system TripleTOF system Quantitation ID with MRM ratio Quantitation ID with MRM ratio ID with MS/MS library searching Quantitation ID with accurate mass ID with MS/MS library searching ID true unknowns Retrospective data processing increasing confidence in compound ID 5 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

In Search of Greater Selectivity Principle of Time-of-Flight (TOF) Mass Spectrometry Ion packets are pulsed and accelerated into a TOF analyzer. Separation of ions is based on the time to traverse the flight tube, and arrive at the detector, on a nanosecond time scale. Smaller m/z ions move faster than heavier m/z ions Higher resolution is achieved with longer flight path (longer TOF tubes, reflectors, faster acceleration). 6 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

All data has been acquired using the AB SCIEX TripleTOF 5600 + System QJet Ion Guide Q0 High Pressure Cell High Frequency Q1 Ion compression optics Accelerator TOF Analyzer 40 GHz Multichannel TDC Detector 30kHz Accelerator Stable mass accuracy of ~1ppm RMS Fully automated calibration of MS and MS/MS LINAC collision cell 15 kv Acceleration voltage Resolution ~30,000 100 Hz acquisition rate Two-stage reflectron Linear dynamic range ~ 4 orders Hybrid quadrupole / time-of-flight (TOF) mass spectrometer 7 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity, with high-resolution measurements Nominal mass instrument, 0.7 Da FWHM High resolution, with TripleTOF 5600 System 8 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity, with high-resolution measurements Nominal mass instrument measures signal from compounds in a wide mass range High-Res / Accurate Mass instrument measures signal from compounds in a narrow mass range! 9 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity compared to Triple Quadrupole Mass Spectrometers, with high-resolution measurements A simple example: 4 different molecular formulae with nominal mass = 28 Da N 2 = 2 X 14.0031 = 28.0061 CO = 12.0000 + 15.9949 = 27.9949 C 2 H 4 = (2 X 12.0000) + (4 X 1.0078) = 28.0312 CH 2 N = 12.0000 + (2 X 1.0078) + 14.0031 = 28.0187 Cannot be distinguished by a nominal mass instrument 10 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity compared to Triple Quadrupole Mass Spectrometers, with high-resolution measurements Improved S/N with narrower XIC extraction windows XIC Peak Width (m/z) 0.70 0.30 0.10 0.02 0.01 1.0 2.0 3.0 4.0 Time, min 11 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity compared to Triple Quadrupole Mass Spectrometers, with high-resolution measurements Improved S/N with narrower XIC extraction windows Possible to re-interrogate data for unanticipated compounds XIC (±5 mda) for: Alprazolam Benzoylecgonine Buprenorphine Carisoprodol Clonazepam Codeine 12 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Why consider TOF technology for screening? Greater specificity compared to Triple Quadrupole Mass Spectrometers, with high-resolution measurements Improved S/N with narrower XIC extraction windows Possible to re-interrogate data for unanticipated compounds Same data. More extracted ion chromatograms. XIC (±5 mda) for: Alprazolam Benzoylecgonine Buprenorphine Carisoprodol Clonazepam Codeine Diazepam EDDP Fentanyl Flunitrazepam Flurazepam Hydrocodone 13 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

The Million $$$ Question(s): Is TOF-MS sufficiently selective? Can we get away from MS/MS if we use a high-resolution accurate mass system? Why ask this question? TOF-MS methods are extremely convenient, because they are generic, and non-targeted No method development is required for new compounds It is possible to re-interrogate the data later, to look for other compounds We know that high-resolution TOF-MS provides far better selectivity than nominal mass (quadrupole) MS instrumentation It is reasonable to wonder if the selectivity of TOF-MS is comparable to MS/MS on a triple quadrupole 14 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Investigation of TOF-MS versus TOF-MS/MS Methods: 50+ compounds were spiked into authentic urine matrix Analysis was performed using both TOF-MS and TOF-MS/MS Extracted ion chromatograms (XICs) were generated using an extraction window of ±5mDa Sample Prep: Spiked urine was diluted 10x with mobile phase A, vortexed, centrifuged, and injected directly onto the MS system HPLC Conditions Flow rate = 500uL/minute Run-time = 6.5 minutes Column = Phenomenex Kinetex C18, 50x3.0mm, 2.6um Mobile phase A = 10mM ammonium formate Mobile phase B = 1:1 methanol:acetonitrile TripleTOF 5600 + System 15 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Investigation of TOF-MS versus TOF-MS/MS Using only TOF-MS, even with a small extraction mass range (+/- 5mDa), there is still a possibility of observing interferences. In spiked urine, many compounds display interferences within the RT window. MS/MS is required for unambiguous ID (either XIC from MS/MS, or library search) OR Chromatographic separation is absolutely essential. MDA Interferences in blank urine Analysis of MDA in urine (TOF-MS) 180.1019 (+/- 5 mda) 16 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Investigation of TOF-MS versus TOF-MS/MS TOF-MS Spiked urine, Sample C MDA 180.1019 (+/- 0.005 Da) Interferences in blank urine TOF-MS Spiked urine, Sample B Interferences 310.2165 (+/- 0.005 Da) Methadone TOF-MS/MS Spiked urine, Sample C MDA 180.1 105.0699 (+/- 0.005 Da) Interferences are removed by MS/MS TOF-MS/MS Spiked urine, Sample B Interferences are removed by MS/MS 310.2 105.0339 (+/- 0.005 Da) TOF-MS Spiked urine, Sample C Morphine Hydromorphone 286.1438 (+/- 0.005 Da) TOF-MS Spiked urine, Sample C Interference 326.2115 (+/- 0.005 Da) Norpropoxyphene TOF-MS/MS Spiked urine, Sample C Interferences are removed by MS/MS 286.1 185.0603 (+/- 0.005 Da) TOF-MS/MS Spiked urine, Sample C Interference is removed by MS/MS 326.2 44.0501 (+/- 0.005 Da) 17 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Investigation of TOF-MS versus TOF-MS/MS With TOF-MS, identification of compounds relies upon: (i) accurate mass measurements (within several ppm of theoretical value) (ii) isotope patterns (matches the expected pattern) Oxazepam (C 15 H 11 ClN 2 O 2 ) Theoretical mass = 287.0582 Dppm = 1.0 Example: TOF-MS enables the separation of Oxazepam from an interference having the same nominal mass. 18 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Investigation of TOF-MS versus TOF-MS/MS With TOF-MS, identification of compounds relies upon (i) accurate mass measurements (within several ppm of theoretical value) (ii) isotope patterns (matches the expected pattern) Problem #1: Accurate mass measurements can be distorted by coeluting, isobaric compounds Problem #2: Isotope patterns can be distorted by co-eluting (nonisobaric!) compounds Sufentanil elutes at 2.60 min, however it was not identified by software! Theoretical m/z = 387.211 Measured m/z = 387.196 Delta = -35 ppm Fentanyl isotope pattern is distorted by an interference Example 1. The measured mass for Sufentanil (RT=2.60 min), spiked into a urine sample, differed from the theoretical accurate mass by -35 ppm, due to the presence of a co-eluting interference. Example 2. The Fentanyl isotope pattern is distorted due to the presence of a coeluting compound, at M+1. 19 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

We conclude that 1. TOF-MS alone is not sufficiently selective for definitive compound ID in complex sample matrices. Interferences are frequently observed in the high-resolution XICs Distorted accurate mass measurements are observed, due to co-eluting interferences Distorted isotope patterns are common, due to co-eluting interferences 2. TOF-MS/MS provides ultra-selective XICs (MRM HR ), that are free from interferences. 3. TOF-MS/MS enables library searching of compound-specific fragmentation patterns. Does not rely solely on accurate mass measurements and isotope patterns 20 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

TOF-MS/MS acquisition, with Scheduled MRM HR 1. TOF-MS is acquired continuously throughout the run 2. TOF-MS/MS scans are triggered at the appropriate RT window for each compound. In this experiment, there are 14 TOF-MS/MS scans (accumulation = 50 msec), to account for the maximum # of overlapping RT windows for 52 target compounds. Experimental Method TOF-MS (+) Product ion (+) 328.2 Product ion (+) 300.2 Product ion (+) 286.1 21 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Software makes data interpretation easy 1. You tell the software what compounds to look for. Compound list Fragment to extract Expected RT Minimum intensity 22 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Software makes data interpretation easy 2. The software automatically assesses / displays all the relevant criteria for compound ID. XICs of TOF-MS or TOF-MS/MS data Confidence scores Error (ppm) RT Delta MS/MS Hits Isotope pattern review MS/MS library search 23 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

MS/MS ALL All truths are easy to understand once they are discovered; the point is to discover them Galileo Galilei 24 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

MS/MS ALL Until we have all the information, we don t even know what questions we should be asking! We have seen that targeted TOF-MS/MS provides the highest selectivity but one needs to know what to target. Ultimate Goal: Collect high-resolution MS/MS information on every analyte in your sample (MS/MS ALL ). Toxicologist s Wishlist: Generic method, non-targeted How to accomplish this??? Maximum selectivity Digital record of everything in your sample Possibility to re-interrogate the data later 25 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

What is SWATH acquisition? It is the collection of MS/MS in a generic and comprehensive fashion Relies on Q1 to provide an additional level of selectivity Wide Q1 isolation window is stepped across the mass range of interest Assists in simplifying MS/MS spectra, and hence the interpretation Filters endogenous precursors that could generate interfering fragment ions Regular MS/MS SWATH MS/MS Q1 filter [0.7] CID TOF analyzer Q1 filter [25Da] CID TOF analyzer 26 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Comparing MRM HR and SWATH acquisition 1. Both techniques employ TOF-MS full-scan Provides accurate mass measurement, and isotope pattern, for parent ions 2. Both techniques employ looped product ion scans MRM HR collects dedicated MS/MS for targeted compounds SWATH collects MS/MS for all compounds by using wide Q1 isolation windows, stepped across a mass range MRM HR SWATH Experimental Method TOF-MS Product ion, 328.2 Product ion, 300.2 Product ion, 286.1 Experimental Method TOF-MS Product ion, 150-170 Product ion, 170-190 Product ion, 510-530 Product ion, 530-550 27 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Processing SWATH -MS/MS Data Same as MRM HR User tells software the mass of the parent ion, and the fragment ion Software automatically extracts XIC from the appropriate SWATH scan (i.e. the mass range containing the parent ion) MS/MS Library Purity Score Mass Error Isotopic Pattern Retention Time 28 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Comparing MRM HR and SWATH acquisition SWATH Name Precursor m/z Fragment m/z Oxycodone 299 325 298.14 Hydrocodone 299 325 199.08 Comparable sensitivity Oxymorphone 299 325 284.13 Hydromorphone 274 300 185.06 Codeine 299 325 215.11 Morphine 274 300 201.09 MRM HR Name Precursor m/z Fragment m/z Oxycodone 316.15 298.14 Hydrocodone 300.16 199.08 Oxymorphone 302.14 284.13 Hydromorphone 286.14 185.06 Codeine 300.16 215.11 Morphine 286.14 201.09 29 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

What about background? MRM HR ( unit Q1 isolation window) Lower background SWATH acquisition (wide Q1 isolation window) Higher background 30 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Comparison of TOF, TOF-MS/MS, and SWATH acquisition for targeted drug screening TOF-MS SWATH TOF-MS/MS TOF-MS/MS (a.k.a. MRM HR ) Generic, non-targeted method Low selectivity (MS only) Retrospective data mining Generic, non-targeted method High selectivity (MS/MS) Retrospective data mining Targeted acquisition method Highest selectivity (MS/MS) Retrospective data mining Interference in blank urine Norpropoxyphene (m/z 326.21) Norpropoxyphene (m/z 326.21) Norpropoxyphene (m/z 326.21) Hydromorphone (m/z 286.14) Hydromorphone (m/z 286.14) Hydromorphone (m/z 286.14) Methadone (m/z 310.22) Interferences in blank urine Methadone (m/z 310.22) Methadone (m/z 310.22) MDA (m/z 180.10) Interferences in blank urine MDA (m/z 180.10) MDA (m/z 180.10) 31 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Comparison of TOF, TOF-MS/MS, and SWATH acquisition for targeted drug screening TOF-MS SWATH TOF-MS/MS TOF-MS/MS (a.k.a. MRM HR ) Generic, non-targeted method Low selectivity (MS only) Retrospective data mining Generic, non-targeted method High selectivity (MS/MS) Retrospective data mining Targeted acquisition method Highest selectivity (MS/MS) Retrospective data mining Interference in blank urine Norpropoxyphene (m/z 326.21) Norpropoxyphene (m/z 326.21) Norpropoxyphene (m/z 326.21) Hydromorphone (m/z 286.14) Hydromorphone (m/z 286.14) Hydromorphone (m/z 286.14) Methadone (m/z 310.22) Interferences in blank urine Methadone (m/z 310.22) Methadone (m/z 310.22) MDA (m/z 180.10) Interferences in blank urine MDA (m/z 180.10) MDA (m/z 180.10) 32 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Comparison of TOF, TOF-MS/MS, and SWATH acquisition for retrospective data analysis MRM HR is a targeted technique no retrospective data mining TOF-MS enables data mining, however lacks selectivity SWATH-MS/MS is generic, selective, and allows retrospective data analysis TOF-MS SWATH TOF-MS/MS TOF-MS/MS (a.k.a. MRM HR ) Generic, non-targeted method Low selectivity (MS only) Retrospective data mining Interference in Flephedrone blank urine (m/z 182.10) Interferences in blank urine Norpropoxyphene (m/z 326.21) Generic, non-targeted method High selectivity (MS/MS) Retrospective data mining Norpropoxyphene (m/z 326.21) Flephedrone (m/z 182.10) Targeted acquisition method Highest selectivity (MS/MS) Retrospective data mining N/A Norpropoxyphene (m/z 326.21) Hydromorphone (m/z 286.14) Mephedrone (m/z 178.12) Hydromorphone (m/z 286.14) Mephedrone (m/z 178.12) Hydromorphone (m/z 286.14) N/A Methadone (m/z 310.22) 33 2015 AB Sciex RUO-MKT-11-1018-A Methadone (m/z For 310.22) research use only. Not for diagnostic procedures. Interferences in blank urine Methadone (m/z 310.22)

Advantages of SWATH acquisition 1. SWATH acquisition method is generic, and non-targeted 2. SWATH data can be reinterrogated for both MS and MS/MS information (and XICs) 3. SWATH cycle time does not increase as the number of target compounds increases 4. Sensitivity of SWATH is comparable to MRM HR, however the background is higher with SWATH Disadvantages of SWATH acquisition 1. SWATH is slightly less selective than MRM HR 2. Background is slightly higher than MRM HR, but better than TOF-MS. 3. SWATH cycle times may be longer Dependent on the mass range covered Dependent on the size of the Q1 isolation windows 34 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Does SWATH acquisition satisfy the wishlist? Toxicologist s Wishlist: SWATH acquisition Generic method, non-targeted Maximum selectivity Digital record of everything in your sample Possibility to re-interrogate the data later 35 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Conclusions High-resolution accurate mass MS systems (e.g. Time-of-Flight) provide incredible selectivity VS nominal mass instruments. MS/MS is required, even on a high-res MS system, to remove chemical interferences and to avoid false positives/negatives. TOF-MS Spiked urine, Sample C MDA 180.1019 (+/- 0.005 Da) Interferences in blank urine TOF-MS/MS Spiked urine, Sample C MDA 180.1 105.0699 (+/- 0.005 Da) Interferences are removed by MS/MS 36 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Conclusions MRM HR acquisition employs looped TOF-MS and TOF-MS/MS scans, to provide: Maximum specificity for all targeted compounds (via MS/MS) Ability to re-interrogate the data, for unanticipated compounds (via MS) Definitive compound ID is achieved by assessing: High-resolution XICs of MS/MS data MS/MS fragmentation pattern Accurate mass Isotope pattern Retention time 37 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Conclusions SWATH acquisition is a mode of Data-Independent Acquisition that provides TOF-MS and TOF-MS/MS information for all compounds in a sample (even unanticipated compounds) enables monitoring of any number of analytes, with no increase in experimental cycle time captures a complete digital record of everything in your sample enables retrospective data analysis Generic method, non-targeted Maximum selectivity Digital record of everything in your sample Possibility to re-interrogate the data later 38 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Trademarks/Licensing For Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners. AB SCIEX is being used under license. AB Sciex is doing business as SCIEX. 2013 AB SCIEX. 39 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.

Questions? 40 2015 AB Sciex RUO-MKT-11-1018-A For research use only. Not for diagnostic procedures.